Puma Biotech (PBYI) Reports Q4 EPS of $0.01

Puma Biotech (NASDAQ: PBYI) reported Q4 EPS of $0.01, versus ($0.32) reported last year. Revenue for the quarter came in at $58.7 million versus the consensus estimate of $59.96 million.

For earnings history and earnings-related data on Puma Biotech (PBYI) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
• Ridgepost Capital acquires Stellus Capital Management for $4B AUM